← Scroll for more →
Financial Statements — SLDE
Balance Sheet
(in billions USD)| Metric | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 0.70 | 1.24 | 1.22 | 1.20 | 0.86 | 0.94 |
| Total Assets | 3.39 | 3.60 | 2.88 | 2.92 | 2.69 | 2.81 |
| Long-term Debt | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 |
| Total Liabilities | 2.09 | 2.40 | 1.77 | 1.81 | 1.72 | 1.95 |
| Retained Earnings | 1.16 | 1.03 | 0.89 | 0.75 | 0.58 | 0.47 |
| Total Stockholder Equity | 1.30 | 1.19 | 1.11 | 1.11 | 0.96 | 0.87 |
← Scroll for more columns →
Income Statement
(in millions USD) (except per-share rows)| Metric | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Net Premiums Earned | 333.35 | 360.64 | 365.88 | 326.57 | 243.05 | 243.86 |
| Total Revenue | 361.05 | 386.82 | 389.28 | 347.01 | 265.69 | 261.61 |
| Tax Provision | 23.52 | 43.61 | 46.15 | 51.63 | 36.02 | 26.23 |
| Net Income | 138.23 | 134.85 | 139.53 | 170.39 | 111.00 | 70.07 |
| Diluted EPS | 1.09 | 1.06 | 1.02 | 1.25 | 0.79 | 0.56 |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | (42.97) | 300.52 | 289.49 | 421.73 | 25.27 | 350.43 |
| Capital Expenditures | 6.31 | 0.42 | 0.68 | 0.54 | 0.82 | 1.50 |
| Free Cash Flow* | (49.28) | 300.11 | 288.81 | 421.19 | 24.46 | 348.93 |
| Investing Cash Flow | (49.57) | (122.85) | (134.07) | (114.58) | (18.09) | 17.49 |
| Financing Cash Flow | (11.52) | (56.92) | (137.99) | (26.38) | (20.74) | 257.99 |
← Scroll for more columns →
* Derived from reported values